These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4148514)

  • 41. Dopaminergic agonists in animal models of parkinsonism.
    Poirier LJ
    Adv Neurol; 1975; 9():327-35. PubMed ID: 807089
    [No Abstract]   [Full Text] [Related]  

  • 42. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man.
    Güell A; Géraud G; Jauzac P; Victor G; Arné-Bès MC
    J Cereb Blood Flow Metab; 1982; 2(2):255-7. PubMed ID: 7076737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism of tricyclic antidepressants. A review.
    Gram LF
    Dan Med Bull; 1974 Oct; 21(6):218-31. PubMed ID: 4609692
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
    Millan MJ; Cussac D; Milligan G; Carr C; Audinot V; Gobert A; Lejeune F; Rivet JM; Brocco M; Duqueyroix D; Nicolas JP; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2001 Jun; 297(3):876-87. PubMed ID: 11356907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biliary excretion and enterohepatic recirculation of methaqualone in the rat.
    Polk A; Delong AF; Smyth RD; Herczeg T; Burns BJ; Klunk LJ; Reavey-Cantwell NH
    Drug Metab Dispos; 1974; 2(4):365-9. PubMed ID: 4153284
    [No Abstract]   [Full Text] [Related]  

  • 47. Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant.
    Ladinsky H; Consolo S; Garattini S
    Life Sci; 1974 Apr; 14(7):1251-60. PubMed ID: 4823638
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on an unusual N-dealkylation reaction. I. In vivo and in vitro N-dealkylation of N-t-butylnorchlorcyclizine to norchlorcyclizine by the rat.
    Kamm JJ; Szuna A; Kuntzman R
    J Pharmacol Exp Ther; 1972 Sep; 182(3):507-14. PubMed ID: 4403434
    [No Abstract]   [Full Text] [Related]  

  • 49. Importance of demethylenation in the metabolism in vivo and in vitro of methylenedioxyphenyl synergists and related compounds in mammals.
    Kamienski FX; Casida JE
    Biochem Pharmacol; 1970 Jan; 19(1):91-112. PubMed ID: 4396245
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
    Eggert K; Öhlwein C; Kassubek J; Wolz M; Kupsch A; Ceballos-Baumann A; Ehret R; Polzer U; Klostermann F; Schwarz J; Fuchs G; Jost W; Albert A; Haag A; Hermsen A; Lohmüller K; Kuhn K; Wangemann M; Oertel WH;
    Clin Neuropharmacol; 2014; 37(4):116-22. PubMed ID: 24992083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amphetamine discrimination as a test for anti-parkinsonism drugs.
    Schechter MD
    Eur J Pharmacol; 1977 Jul; 44(1):51-6. PubMed ID: 885158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.
    Creese I
    Eur J Pharmacol; 1974 Sep; 28(1):55-8. PubMed ID: 4473347
    [No Abstract]   [Full Text] [Related]  

  • 53. [Piribedil, dopaminergic agonist. Prolonged clinical and electrophysiological study in 60 parkinsonian patients (author's transl)].
    Truelle JL; Chanelet J; Bastard J; Six P; Emile J
    Nouv Presse Med; 1977 Oct; 6(33):2987-90. PubMed ID: 22844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ditazol metabolism in rat, rabbit and man.
    Marchetti E; Mattalia G; Bergesi G
    Arzneimittelforschung; 1973 Sep; 23(9):1291-5. PubMed ID: 4801223
    [No Abstract]   [Full Text] [Related]  

  • 55. The metabolism of ibuprofen.
    Mills RF; Adams SS; Cliffe EE; Dickinson W; Nicholson JS
    Xenobiotica; 1973 Sep; 3(9):589-98. PubMed ID: 4202799
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolic and clinical observations on metiapine in humans.
    Wright GJ; Hook RH; Blackwell B
    Adv Biochem Psychopharmacol; 1974; 9(0):445-55. PubMed ID: 4836218
    [No Abstract]   [Full Text] [Related]  

  • 57. Piribedil-induced sleep attacks in patients without Parkinson disease: a case series.
    Gouraud A; Millaret A; Descotes J; Vial T;
    Clin Neuropharmacol; 2011; 34(3):104-7. PubMed ID: 21586915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
    Marighetto A; Valerio S; Philippin JN; Bertaina-Anglade V; Drieu la Rochelle C; Jaffard R; Morain P
    J Psychopharmacol; 2008 Jul; 22(5):511-21. PubMed ID: 18308794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole.
    Borchert P; Wislocki PG; Miller JA; Miller EC
    Cancer Res; 1973 Mar; 33(3):575-89. PubMed ID: 4689905
    [No Abstract]   [Full Text] [Related]  

  • 60. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.
    Caccia S; Conti I; Viganò G; Garattini S
    Pharmacology; 1986; 33(1):46-51. PubMed ID: 2874572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.